Why the study?
Studies in low- and middle-income countries were lacking, prompting an assessment of the prevalence and determinants of hypertension treatment and control in Myanmar.
What is the prevalence and what are the factors associated with treatment and control of hypertension among adults in Myanmar?
What is the prevalence and what are the factors associated with treatment and control of hypertension among adults in Myanmar?
In a Myanmar cohort, hypertension treatment and control rates were low (48.1% and 20.5%), emphasizing the need for improved management strategies targeting younger and less educated individuals.
Findings on hypertension control determinants in Myanmar are hypothesis-generating; leaves open need for interventional studies in LMICs.
BACKGROUND: Due to a dearth in the number of studies conducted in low- and middle-income countries, this study aimed to identify the prevalence and determinants of the treatment and control of hypertension among patients with hypertension in Myanmar. METHODS: This community-based cross-sectional study was conducted among 410 adults who were registered for hypertensive treatment in health centers in Myitkyina Township, Kachin State, Myanmar. Multiple logistic regression was used to identify the associated factors. RESULTS: The prevalence of treatment and control of hypertension was 48.1% and 20.5%, respectively. The factors associated with treatment were age (OR=2.60 for 46-60 y and OR=2.29 for 61-70 y compared with 30-45 y), ethnicity (OR=1.87), monthly family income (OR=1.90), comorbidity (OR=2.33), knowledge (OR=2.63) and adherence to physical activity (OR=1.86). Controlled hypertension was associated with age (OR=3.03 for 46-60 y and OR=2.27 for 61-70 y compared with 30-45 y), education (OR=1.81), comorbidity (OR=1.67) and adherence to medication (OR=3.45). CONCLUSIONS: The prevalence of treated and controlled hypertension was relatively low in this study. To improve the prevalence of hypertension treatment and control in this study population, effective and culturally sensitive intervention programs under universal health coverage should be established with an emphasis on individuals with lower educational attainment and younger ages.
No takes yet. Share an insight, caveat, or question.
Haung et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: